Cargando…
Implementation of a risk mitigating COVID-adapted colorectal cancer pathway
Autores principales: | Miller, Janice, Thomson, Laura J, Stewart, Lisa S P, Fleming, Jenny, Dunlop, Malcolm G, Din, Farhat V N, Maeda, Yasuko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802393/ https://www.ncbi.nlm.nih.gov/pubmed/33431430 http://dx.doi.org/10.1136/bmjoq-2020-001135 |
Ejemplares similares
-
Development of a customised data management system for a COVID-19-adapted colorectal cancer pathway
por: Miller, Janice, et al.
Publicado: (2021) -
Short‐term outcomes of a COVID‐adapted triage pathway for colorectal cancer detection
por: Miller, Janice, et al.
Publicado: (2021) -
Author response to: Comment on: Double faecal immunochemical testing in patients with symptoms suspicious of colorectal cancer
por: Gerrard, Adam D, et al.
Publicado: (2023) -
Risk of missing colorectal cancer with a COVID-adapted diagnostic pathway using quantitative faecal immunochemical testing
por: Maeda, Y, et al.
Publicado: (2021) -
Adapting the stages of implementation completion to an evidence-based implementation strategy: The development of the NIATx stages of implementation completion
por: Ford, James H., et al.
Publicado: (2023)